home / stock / asp:cc / asp:cc news

ASP:CC News and Press, Acerus Pharmaceuticals Corporation

Stock Information
Company Name: Acerus Pharmaceuticals Corporation
Stock Symbol: ASP:CC
Market: TSXC
Website: aceruspharma.com
Menu
ASP:CC ASP:CC Quote ASP:CC Short ASP:CC News ASP:CC Articles ASP:CC Message Board
Get ASP:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
ASP:CC - Acerus Update

TORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- As announced on January 26, 2023, Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) and its subsidiaries were granted creditor protection pursuant to an order (the “ Initial Order ”) g...
ASP:CC - Acerus Announces Commencement of Court-Approved Sale and Investment Solicitation Process

TORONTO, March 14, 2023 (GLOBE NEWSWIRE) -- On January 26, 2023, Acerus Pharmaceuticals Corporation and certain of its subsidiaries (collectively, “ Acerus ”) were granted protection pursuant to an order (the “ Initial Order ”) issued under the Companies ...

ASP:CC - Acerus Files For CCAA Protection

TORONTO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX: ASP; OTCQB: ASPCF) today announced that the Company and its subsidiaries, Acerus Biopharma Inc., Acerus Labs Inc. and Acerus Pharmaceuticals USA,...

ASP:CC - IIROC Trading Halt - ASP

IIROC Trading Halt - ASP Canada NewsWire TORONTO , Jan. 26, 2023 /CNW/ - The following issues have been halted by IIROC: Company: Acerus Pharmaceuticals Corporation TSX Symbol: ASP All Issues: Yes Reason: Pending News Halt Time (ET): ...
ASP:CC - Acerus Announces Resignation of Director

TORONTO, Dec. 26, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX: ASP; OTCQB: ASPCF) today announced that Mr. Scott Leckie has resigned from the board of directors of the Company, effective immediately. ...

ASP:CC - Acerus Announces New Loan Agreement With First Generation Capital

TORONTO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX: ASP; OTCQB: ASPCF) today announced that it and its wholly-owned subsidiary, Acerus Pharmaceuticals USA, LLC (collectively with the Company, the &...

ASP:CC - Acerus Reports Third Quarter 2022 Financial Results

TORONTO, Nov. 15, 2022 (GLOBE NEWSWIRE) --  Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three and nine-month period ended September 30, 2022. Unless otherwise noted, all...
ASP:CC - Acerus Announces Amendment to Promissory Note Due to Former Serenity Shareholders

TORONTO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX:ASP; OTCQB:ASPCF) today announced that it has amended the promissory note (the “ Note ”) in the amount of US$4.91 million ...

ASP:CC - Acerus Announces Initiation of Strategic Review

Ernst & Young Orenda Corporate Finance Inc. (“EY”) engaged as independent financial advisors TORONTO, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX: ASP; OTCQB: A...

ASP:CC - Acerus Announces Resignation of CFO Effective November 20, 2022

TORONTO, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX:ASP; OTCQB:ASPCF) today announced that Robert Motz has informed the Company of his decision to resign as Chief Financial Officer effective N...
Next 10